News & Updates
Filter by Specialty:
Extended-release nifedipine benefits women with severe pre-eclampsia
Treatment with extended-release nifedipine helps reduce intrapartum acute hypertensive therapy among pre-eclampsia patients with severe features, as reported in a study.
Extended-release nifedipine benefits women with severe pre-eclampsia
02 Nov 2022
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
Patients with concomitant chronic kidney disease (CKD) and type 2 diabetes (T2D) who are undergoing mineralocorticoid receptor blockade with finerenone are better protected against pneumonia and COVID-19, according to a secondary analysis of data from the FIDELITY trials.
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
02 Nov 2022
Freshwater fish-based diet eases liver steatosis in NAFLD patients
Adherence to a freshwater fish-based diet helps regulate the gut microbiota and its metabolites, suggesting benefits in individuals with nonalcoholic fatty liver disease (NAFLD), reveals a study.
Freshwater fish-based diet eases liver steatosis in NAFLD patients
02 Nov 2022
TNF inhibition beyond 24 weeks: How safe in pregnant mums?
Continued treatment with tumor necrosis factor (TNF) inhibitors after 24 weeks of pregnancy appears safe and is associated with lower chances of maternal inflammatory bowel disease (IBD) relapse, without increasing adverse neonatal outcomes, new research suggests.
